PDA seeks members’ view before responding to CPhO view of pharmacy leadership


Share post:

The Pharmacists’ Defence Association (PDA) has urged its member – employed pharmacists and locum pharmacists to share their view on UK Commission on Pharmacy Professional Leadership report.

The four government Chief Pharmacists have published their commission’s proposal for how pharmacy leadership may develop in the UK.

The association ‘strongly’ believes that just as it was the members of the profession that established their previous pharmacist professional leadership bodies, so it is for pharmacists to determine if they agree with these proposals and to decide what arrangements they want in future.

“As an organisation that has exclusively in its membership the employed and locum pharmacists in the UK, the PDA wants to ensure that it can reflect the views of frontline pharmacists in any future discussions and decisions that could impact upon their careers.

Pharmacists are encouraged to read the report, to consider its content and then ensure they respond to the forthcoming communication from the PDA.”

The commission report says that existing leadership bodies have “relatively low levels of membership” but does not provide details. It has also stated that it has received submissions to its consultation from many pharmacy organisations.

PDA said: “The commission has been funded by public money and this brings with it significant additional need for transparency and accountability.

If its proposals are to secure the confidence of the wider pharmacist profession, then it should publish the details of the membership numbers of the bodies that it is now recommending form the leadership council. It should also publish the submissions that it has received as contributions to its commission from pharmacy bodies.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...